EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

New-Onset Myasthenia Gravis Associated with SARS-CoV-2 Infection: A Systematic Review

Amalia L Călinoiu, Alexandra Mincă iD, Claudiu C Popescu iD, Ileana M Vodă iD, Alexandra M Cristea iD, Dragoș I Mincă

Life · 30.06.2026 · 16 (7) · 1100

DOI: 10.3390/life16071100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 30.06.2026. Verfasst von Amalia L Călinoiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: "Prof. Dr. Agrippa Ionescu" Emergency Clinical Hospital, 011356 Bucharest, Romania. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic literature review synthesizes available data from published case reports and case studies describing de novo myasthenia gravis (MG) following confirmed SARS-CoV-2 infection, focusing on clinical presentation, immunological characteristics, temporal relationship, management, and outcomes. The study addresses the following research question: What are the clinical, immunological, temporal, and outcome characteristics of de novo MG following SARS-CoV-2 infection based on published case reports and case studies? Following the PRISMA 2020 guidelines, the analysis included 44 studies describing 48 patients. The findings suggest that MG temporally associated with COVID-19 typically occurred within a relatively short latency period, with a median interval of 21 days. Most patients presented with generalized onset and were predominantly positive for AChR-Abs, consistent with the established clinical and serological profile of classical MG, in which AChR-Abs represent the most common subtype, particularly in generalized disease. MuSK and LRP4-positive cases were less frequent; ICU admission, myasthenic crisis, and respiratory failure were frequently reported. Importantly, most patients responded well to conventional MG therapies.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Long-COVIDSARS-CoV-2 infectionmyasthenia gravis

Autor:innen und Institutionen

  • "Prof. Dr. Agrippa Ionescu" Emergency Clinical Hospital, 011356 Bucharest, Romania.
  • Public Health and Management Department, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Rheumatology Department, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Bucharest University Emergency Hospital, 050098 Bucharest, Romania.
  • Pneumology I Department, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania.

ORCID-Profile: Alexandra Mincă, Claudiu C Popescu, Ileana M Vodă, Alexandra M Cristea

Zitieren

APA

Călinoiu, A. L., Mincă, A., Popescu, C. C., Vodă, I. M., Cristea, A. M., & Mincă, D. I. (2026). New-Onset Myasthenia Gravis Associated with SARS-CoV-2 Infection: A Systematic Review. Life, 16(7), 1100. https://doi.org/10.3390/life16071100

Vancouver

Călinoiu AL, Mincă A, Popescu CC, Vodă IM, Cristea AM, Mincă DI. New-Onset Myasthenia Gravis Associated with SARS-CoV-2 Infection: A Systematic Review. Life. 2026;16(7):1100. doi:10.3390/life16071100

BibTeX
@article{Clinoiu2026,
  author = {Călinoiu, Amalia L and Mincă, Alexandra and Popescu, Claudiu C and Vodă, Ileana M and Cristea, Alexandra M and Mincă, Dragoș I},
  title = {New-Onset Myasthenia Gravis Associated with SARS-CoV-2 Infection: A Systematic Review},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {1100},
  doi = {10.3390/life16071100}
}
Kostenlos starten →